NASDAQ
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), today announced that the company granted inducement equity awards covering an aggregate of 7,800 shares of its common sto...
Shares of Scholar Rock Holding Corporation (NASDAQ: SRRK - Get Free Report) have earned a consensus rating of "Buy" from the sixteen research firms that are covering the stock, MarketBeat reports. One...
Federated Hermes Inc. increased its position in Scholar Rock Holding Corporation (NASDAQ: SRRK) by 10,809.9% during the second quarter, according to the company in its most recent 13F filing with the ...
Fisher Asset Management LLC lowered its position in shares of Scholar Rock Holding Corporation (NASDAQ: SRRK) by 9.7% in the undefined quarter, according to its most recent disclosure with the SEC. Th...
Scholar Rock Holding Corporation (SRRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript...
New York City-based Commodore Capital sold nearly 1.5 million shares of Scholar Rock, a net position change of about $51 million. The transaction value was approximately 2.5% of Commodore Capital LP's...
Scholar Rock Holding Corporation ( SRRK ) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Company Participants Laura Ekas David Hallal - CEO & Chairman of the Board Akshay Vaishnaw - President of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal muscular atrophy (SM...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 30,000 shares of its common sto...
Earnings season often shines a spotlight on well-known mega-caps, but it can also bring opportunities for lesser-known companies to shine. Below are three stocks—each down significantly in 2025—that c...
No price data available for this timeframe.